Roberto Cuca - 21 Feb 2025 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
COO and CFO
Signature
/s/ Megan Smeykal, Attorney-in-fact
Issuer symbol
TELA
Transactions as of
21 Feb 2025
Net transactions value
-$14,236
Form type
4
Filing time
25 Feb 2025, 16:58:19 UTC
Previous filing
24 Oct 2024
Next filing
24 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +57,000 +36% $0.000000 213,467 21 Feb 2025 Direct F1, F2
transaction TELA Common Stock Tax liability $14,236 -5,234 -2.5% $2.72 208,233 23 Feb 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Award $0 +83,800 $0.000000 83,800 21 Feb 2025 Common Stock 83,800 $2.72 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 21, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2 Includes 1,079 shares acquired under the Company's employee stock purchase plan on January 31, 2025.
F3 Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
F4 The option vests 25% on February 21, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.